Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Reviewed by Ware Kuschner, MD, Professor of Medicine, Division ...

Please provide your email address to receive an email when new articles are posted on . Bifidobacterium infantis 35624 can decrease levels of dysfunctional T regulatory cells. There were no ...

An asthma self-management app paired with wearables improved asthma control for adults in a randomized controlled trial. African American patients gained less from the digital intervention. The study ...

In adults with asthma, a digital asthma self-management (DASM) program improved symptom control compared with usual care, although its effectiveness varied by race, with weaker results observed among ...

The digital asthma self-management program significantly improved symptom control, especially for those with uncontrolled asthma, showing a 2.8-point Asthma Control Test score difference over usual ...

Elevance Health and UC Irvine study underscores potential of digital health tools to reduce asthma burden across U.S. populations INDIANAPOLIS--(BUSINESS WIRE)--A groundbreaking clinical trial led by ...

Please provide your email address to receive an email when new articles are posted on . The addition of oral azithromycin to standard treatment improved asthma control and reduced exacerbations ...

Chennai, Feb. 18 -- Highlights: ...

Not all children and teens with active asthma are achieving adequate control of their symptoms, and timely referral to secondary care is rare, according to one study. There is a prevalence of poorly ...

Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.